Condition (MeSH)
Tracheal Neoplasms
ClinicalTrials.gov lists 3 trials for Tracheal Neoplasms or a narrower condition beneath it. Valerio Therapeutics has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
3 of the 3 trials are tagged with Tracheal Neoplasms itself; the rest are tagged with a narrower condition beneath it.
When did Tracheal Neoplasms trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2023 | 1 |
| 2011 | 1 |
| 2005 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Tracheal Neoplasms trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Phase 2 | 1 |
How many Tracheal Neoplasms trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 2 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Tracheal Neoplasms trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Valerio Therapeutics | 1 |
Which publications cover Tracheal Neoplasms? (14)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Endoscopic treatment of tracheal stenosis. | Thoracic surgery clinics | 2014 | Yes |
| Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. | International journal of pediatric otorhinolaryngology | 2010 | Yes |
| Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. | International journal of pediatric otorhinolaryngology | 2009 | Yes |
| Treatment of locally advanced adenoid cystic carcinoma of the trachea with neutron radiotherapy. | International journal of radiation oncology, biology, physics | 2008 | Yes |
| Long-term results after carinal resection for carcinoma: does the benefit warrant the risk? | The Journal of thoracic and cardiovascular surgery | 2006 | Yes |
Showing 5 of 14 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.